Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

ANK C/X Impl A6,6/D3,5/L6,6: medical device reports filed with FDA

1,771 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

1,771
device reports naming the brand
0% of all MAUDE reports · about 250 a year
247
reports, 12 months to August 2026
208 in the 12 months before
0.1%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,771 medical device reports received by FDA name the brand "ANK C/X Impl A6,6/D3,5/L6,6" (implant endosseous root-form); the manufacturer given most often on reports is Dentsply Implants Manufacturing; received from June 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

247 reports arrived in the 12 months to August 2026, up 19% from 208 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.9%) and malfunction (0.1%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (50%), osseointegration problem (27.9%) and loss of osseointegration (20.6%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02856Sep 2021: 25Oct 2021: 17Nov 2021: 14Dec 2021: 272022Jan 2022: 36Feb 2022: 16Mar 2022: 43Apr 2022: 38May 2022: 56Jun 2022: 38Jul 2022: 22Aug 2022: 14Sep 2022: 22Oct 2022: 28Nov 2022: 26Dec 2022: 192023Jan 2023: 24Feb 2023: 27Mar 2023: 26Apr 2023: 43May 2023: 31Jun 2023: 25Jul 2023: 21Aug 2023: 30Sep 2023: 30Oct 2023: 29Nov 2023: 25Dec 2023: 182024Jan 2024: 27Feb 2024: 17Mar 2024: 27Apr 2024: 14May 2024: 31Jun 2024: 20Jul 2024: 34Aug 2024: 24Sep 2024: 16Oct 2024: 15Nov 2024: 15Dec 2024: 72025Jan 2025: 22Feb 2025: 22Mar 2025: 30Apr 2025: 8May 2025: 15Jun 2025: 18Jul 2025: 22Aug 2025: 18Sep 2025: 16Oct 2025: 11Nov 2025: 15Dec 2025: 282026Jan 2026: 21Feb 2026: 48Mar 2026: 16Apr 2026: 22May 2026: 8Jun 2026: 30Jul 2026: 23Aug 2026: 9

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01973942019: 4120192021: 39420212022: 35820222023: 32920232024: 24720242025: 22520252026: 1772026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99.9%1,770
Malfunction0.1%1
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%1,771
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate88650%62.8%
Osseointegration problem49427.9%7.7%
Loss of osseointegration36420.6%22.4%
Fracturea broken bone211.2%1.6%
Malposition of device30.2%0.1%
Patient-device incompatibilitythe device did not suit the patient20.1%0%
Separation failure20.1%0.1%
Damaged thread10.1%0%
Difficult to insertthe device was hard to insert10.1%0.4%
Loosening of implant not related to bone-ingrowth10.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant1,76899.8%
Inflammationinflammation17910.1%
Osteolysis1236.9%
Pocket erosion804.5%
Implant pain100.6%
Neuropathy20.1%
Discomfortdiscomfort10.1%
Osteopenia/ osteoporosis10.1%
Periprosthetic fracture10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureANK C/X Impl A6,6/D3,5/L6,6Product code DZEAll MAUDE reports
Reports1,7713,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury99.9%99.2%36.2%
Classified as malfunction0.1%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about ANK C/X Impl A6,6/D3,5/L6,6 reports

How many FDA reports name ANK C/X Impl A6,6/D3,5/L6,6?

1,771 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 247 in the latest 12 months.

What kinds of events are reported?

injury (99.9%) and malfunction (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (50%), osseointegration problem (27.9%), loss of osseointegration (20.6%), fracture (1.2%) and malposition of device (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that ANK C/X Impl A6,6/D3,5/L6,6 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.